Overcoming COVID-19 Investigators Selected Research

Overcoming COVID-19 Investigators Research Topics

17	COVID-19 04/2024 - 01/2020
8	COVID-19 related pediatric multisystem inflammatory disease 01/2023 - 01/2021
3	Critical Illness (Critically Ill) 04/2024 - 05/2022
3	Disease Progression 01/2023 - 05/2022
3	Fever (Fevers) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 03/2024
1	Neoplasms (Cancer) 03/2024
1	Central Nervous System Infections (Central Nervous System Infection) 01/2023
1	Demyelinating Diseases (Demyelinating Disease) 01/2023
1	Human Influenza (Influenza) 01/2023
1	Aseptic Meningitis 01/2023
1	Neurologic Manifestations (Neurological Manifestations) 01/2023
1	Obesity 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Ventricular Dysfunction 01/2023
1	Weight Gain 11/2022
1	Left Ventricular Dysfunction 01/2021
1	Shock 01/2021
1	Infections 01/2020

6	VaccinesIBA 04/2024 - 10/2021
5	Messenger RNA (mRNA)IBA 12/2023 - 10/2021
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2023 - 01/2020
3	GlucocorticoidsIBA 01/2023 - 01/2021
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023 - 01/2021
2	COVID-19 VaccinesIBA 04/2024 - 09/2023
2	BNT162 VaccineIBA 01/2023 - 01/2022
1	mRNA VaccinesIBA 04/2024
1	Stored Messenger RNAIBA 09/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Notch ReceptorsIBA 01/2023
1	AntigensIBA 10/2022
1	AntibodiesIBA 02/2022
1	AT 61IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020

4	Therapeutics 01/2023 - 01/2021
2	Critical Care (Surgical Intensive Care) 03/2024 - 01/2023
2	Extracorporeal Membrane Oxygenation 12/2023 - 01/2023
2	Length of Stay 01/2023 - 01/2023
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2023
1	Organ Transplantation 03/2024
1	Tracheostomy 01/2023